Also a share holder here, and I am comfortable with CBR's forecast and approach to this global melt-down.But as usual, those with no money invested in the company whatsoever seem to be the most vocal/offended/hurt.Go figure.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%